Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity
Molecules · 05.01.2023 · 28 (2) · 525
DOI: 10.3390/molecules28020525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.01.2023. Verfasst von Hiroki Tanabe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Welfare Science, Nayoro City University, Nayoro 096-8641, Hokkaido, Japan. Hauptthemen laut MEDLINE: Catechin, Matrix Metalloproteinases, NF-kappa B, Antineoplastic Agents. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Epidemiological studies have shown that the consumption of green tea has beneficial effects against cancer. Basic studies have provided evidence that epigallocatechin gallate (EGCG) is a major contributor to these effects. Matrix metalloproteinases (MMPs) are zinc-dependent metalloproteinases with the ability to degrade the extracellular matrix proteins and are involved in various diseases including cancer in which MMPs have a critical role in invasion and metastasis. In this review, we discuss the effects of EGCG on several types of MMPs in the context of its anticancer activity. In the promoter region, MMPs have binding sites for at least one transcription factor of AP-1, Sp1, and NF-κB, and EGCG can downregulate these transcription factors through signaling pathways mediated by reactive oxygen species. EGCG can also decrease nuclear ERK, p38, heat shock protein-27 (Hsp27), and β-catenin levels, leading to suppression of MMPs’ expression. Other mechanisms by which EGCG inhibits MMPs include direct binding to MMPs to prevent their activation and downregulation of NF-κB to suppress the production of inflammatory cytokines such as TNFα and IL-1β. Findings from studies on EGCG presented here may be useful in the development of more effective anti-MMP agents, which would give beneficial effects on cancer and other diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health and Welfare Science, Nayoro City University, Nayoro 096-8641, Hokkaido, Japan.
- Department of Food Science and Nutrition, Faculty of Human Life and Science, Doshisha Women's College of Liberal Arts, Kyoto 602-0893, Japan.
- Institute of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Research Foundation, Numazu 410-0301, Shizuoka, Japan.
- Institute of Microbial Chemistry (BIKAKEN), Laboratory of Oncology, Microbial Chemistry Research Foundation, Shinagawa, Tokyo 141-0021, Japan.
- Tea Science Center, University of Shizuoka, Suruga-ku, Shizuoka 422-8526, Japan.
ORCID-Profile: Takuji Suzuki, Tomokazu Ohishi, Mamoru Isemura, Keiko Unno
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Tanabe, H., Suzuki, T., Ohishi, T., Isemura, M., Nakamura, Y., & Unno, K. (2023). Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules, 28(2), 525. https://doi.org/10.3390/molecules28020525
Vancouver
Tanabe H, Suzuki T, Ohishi T, Isemura M, Nakamura Y, Unno K. Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. Molecules. 2023;28(2):525. doi:10.3390/molecules28020525
BibTeX
@article{Tanabe2023,
author = {Tanabe, Hiroki and Suzuki, Takuji and Ohishi, Tomokazu and Isemura, Mamoru and Nakamura, Yoriyuki and Unno, Keiko},
title = {Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity},
journal = {Molecules},
year = {2023},
volume = {28},
number = {2},
pages = {525},
doi = {10.3390/molecules28020525}
}
EUVIMED